Depression: Chronophysiology and chronotherapy

Biological Rhythm Research

Volumn 45, Issue 1, 2014, Pages 77-91

  Dridi, Dorra ^a   Zouiten, Amina ^a   Mansour, Hedi Ben ^a  

^a UNIVERSITY OF MANOUBA   (Tunisia)

Author keywords

agomelatine; chronotherapy; depression; melatonin; sleep disturbances

Indexed keywords

AGOMELATINE; MELATONIN; PLACEBO;

ANTAGONISM; CIRCADIAN RHYTHM; DRUG; HEALTH CARE; LIGHT EFFECT; SLEEP;

AGITATION; ANTIDEPRESSANT ACTIVITY; ANXIETY; APPETITE; AROUSAL; ARTICLE; AUTUMN; BEDTIME DOSAGE; BIPOLAR DISORDER; BODY TEMPERATURE; CHRONOTHERAPY; CIRCADIAN RHYTHM; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYE DISEASE; EYE MOVEMENT; EYESTRAIN; FUNCTIONAL NEUROIMAGING; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HAMILTON SCALE; HEADACHE; HOSPITALIZATION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPERCORTISOLISM; HYPERSOMNIA; INSOMNIA; LIGHT DARK CYCLE; LIGHT EXPOSURE; LUMINANCE; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD DISORDER; MOTOR ACTIVITY; NAUSEA; OSCILLATION; OUTCOME ASSESSMENT; PATHOGENESIS; PATIENT COMPLIANCE; PHOTOTHERAPY; PINEAL BODY; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIMARY INSOMNIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE RISK; RELAPSE; REM SLEEP; REMISSION; SEASONAL AFFECTIVE DISORDER; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY; SLEEP STAGE; SLEEP TIME; SLEEP WAKING CYCLE; SLOW WAVE SLEEP; SOCIAL RHYTHM THERAPY; SOMNOLENCE; STRESS; SUPRACHIASMATIC NUCLEUS; THERAPY EFFECT; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WAKEFULNESS; WEIGHT GAIN; WINTER; WITHDRAWAL SYNDROME;

EID: 84890556046     PISSN: 09291016     EISSN: 17444179     Source Type: Journal    
DOI: 10.1080/09291016.2013.797657     Document Type: Article

References (141)

1. Almeida OP, Pfaff JJ. 2005. Sleep complaints among older general practice patients: association with depression. Br J Gen Pract. 55:864-866.
2. Arendt J, Skene DJ. 2005. Melatonin as a chronobiotic. Sleep Med Rev. 9:25-39.
3. Armitage R. 2007. Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand. 433:104-115.
4. Armitage R, Hoffmann RF. 2001. Sleep EEG, depression and gender. Sleep Med Rev. 5:237-246.
5. Avery DH, Wildschiodtz G, Rafaelsen OJ. 1982. Nocturnal temperature in affective disorder. J Affect Disord. 4:61-71.
6. Barbini B, Benedetti F, Columbo C, Dotoli D, Bernasconi A, Cigala-Fulgosi M, Florita M, Smeraldi E. 2005. Dark therapy for mania: a pilot study. Bipolar Disord. 7:98-101.
7. Beck-Friis J, Kjellman BF, Aperia B, Undén F, von Rosen D, Ljunggren JG, Wetterberg L. 1985. Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr Scand. 71:319-330.
8. Benedetti F, Barbini B, Lucca A, Campori E, Colombo C, Smeraldi E. 1997. Sleep deprivation hastens the antidepressant action of fluoxetine. Eur Arch Psychiatry Clin Neurosci. 247:100-103.
9. Benedetti F, Colombo C, Barbini B, Campori E, Smeraldi E. 1999. Ongoing lithium treatment prevents relapse after total sleep deprivation. J Clin Psychopharmacol. 19:240-245.
10. Benedetti F, Colombo C, Pontiggia A, Bernasconi A, Florita M, Smeraldi E. 2003. Morning light treatment hastens the antidepressant effect of citalopram: a placebo-controlled trial. J Clin Psychiatry. 64:648-653.
11. Boivin DB. 2000. Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders. J Psychiatry Neurosci. 35:446-458.
12. Brainard GC, Hanifin JP, Greeson JM, Byrne B, Glickman G, Gerner E, Rollag MD. 2002. Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci. 21:6405-6412.
13. Brown LF, Reynolds CF, Monk TH, Prigerson HG, Dew MA, Houck PR, Mazumdar S, Buysse DJ, Hoch CC, Kupfer DJ. 1996. Social rhythm stability following late-life spousal bereavement: associations with depression and sleep impairment. Psychiatry Res. 62:161-169.
14. Buijs RM, Kalsbeek A. 2001. Hypothalamic integration of central and peripheral clocks. Nat Rev Neurosci. 2:521-526.
15. Bunney WE., Bunney BG. 2000. Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression. Neuropsychopharmacology. 22:335-345.
16. Bunney WE, Murphy DL, Goodwin FK, Borge GF. 1970. The switch process from depression to mania: relationship to drugs which alter brain amines. Lancet. 1:1022-1027.
17. Buysse DJ, Nofzinger EA, Germain A, Meltzer CC, Wood A, Ombao H, Kupfer DJ, Moore RY. 2004. Regional brain glucose metabolism during morning and evening wakefulness in humans: preliminary findings. Sleep. 27:1245-1254.
18. Cajochen C, Krauchi K, Mori D, Graw P, Wirz-Justice A. 1997. Melatonin and S-20098 increase REM sleep and wake-up propensity without modifying NREM sleep homeostasis. Am J Physiol. 272:1189-1196.
19. Cardinali DP, Pévet P. 1998. Basic aspects of melatonin action. Sleep Med Rev. 2:175-190.
20. Cardinali DP, Furio AM, Reyes MP, Brusco LI. 2006. The use of chronobiotics in the resynchronization of the sleep/wake cycle. Cancer Causes Control. 17:601-609.
21. Carvalho LA, Gorenstein C, Moreno RA, Markus RP. 2006. Melatonin levels in drug-free patients with major depression from the southern hemisphere. Psychoneuroendocrinology. 31:761-768.
22. Claustrat B, Chazot G, Brun J, Jordan D, Sassolas G. 1984. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression. Biol Psychiatry. 19:1215-1228.
23. Claustrat B, Brun J, Chazot G. 2005. The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 9:11-24.
24. Colombo C, Lucca A, Benedetti F, Barbini B, Campori E, Smeraldi E. 2000. Total sleep deprivation combined with lithium and light therapy in the treatment of bipolar depression: replication of main effects and interaction. Psychiatry Res. 95:43-53.
25. Crasson M, Kjiri S, Colin A, Kriri K, L'Hermite-Baleriaux M, Ansseau M, Kjiri K, L'Hermite- Baleriaux M, Ansseau M, Legros JJ. 2004. Serum melatonin and urinary 6-sulphatoxymelatonin in major depression. Psychoneuroendocrinology. 29:1-12.
26. Dalton EJ, Rotondi D, Levitan RD, Kennedy SH, Brown GM. 2000. Use of slow-release melatonin in treatment-resistant depression. J Psychiatry Neurosci. 25:48-52.
27. Delagrange P, Boutin JA. 2006. Therapeutic potential of melatonin ligands. Chronobiol Int. 23:413-418.
28. Dubocovich ML. 2006. Agomelatine targets a range of major depressive disorder symptoms. Curr Opin Investig Drugs. 7:670-680.
29. Eastman CI, Young MA, Fogg LF, Liu L, Meaden PM. 1998. Bright light treatment of winter depression: a placebo-controlled trial. Arch Gen Psychiatry. 55:883-889.
30. Edinger JD, Wohlgemuth WK, Krystal AD, Rice Jr. 2005. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med. 165:2527-2535.
31. Ehlers CL, Frank E, Kupfer DJ. 1988. Social zeitgebers and biological rhythms: a unified approach to understanding the etiology of depression. Arch Gen Psychiatry. 45:948-952.
32. Ehlers CL, Kupfer DJ, Frank E, Monk TH. 1993. Biological rhythms and depression: the role of zeitgebers and zeitstoreres. Depression. 1:285-293.
33. Frank E, Hlastala S, Ritenour A, Houck P, Tu XM, Monk TH, Mallinger AG, Kupfer DJ. 1997. Inducing lifestyle regularity in recovering bipolar disorder patients: results from the maintenance therapies in bipolar disorder protocol. Biol Psychiatry. 41:1165-1173.
34. Frank E, Kupfer DJ, Thase ME, Mallinger AG, Swartz HA, Fagiolini AM, Grochocinski V, Houck P, Scott J, Thompson W, Monk T. 2005. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry. 62:996-1004.
35. Franzen PL, Buysse DJ. 2008. Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clin Neurosci. 10:473-481.
36. Fuchs E, Simon M, Schmelting B. 2006. Pharmacology of a new antidepressant: benefit of the implication of the melatonergic system. Int Clin Psychopharmacol. 21:17-20.
37. Gaspar-Barba, E, Calati, R, Cruz-Fuentes, C.S, Ontiveros-Uribe, MP, Natale, V, De Ronchi, D, Serretti, A. 2009. Depressive symptomatology is influenced by chronotypes. J Affect Disord. 2009 Mar 12. [Epub ahead of print].
38. Germain A, Kupfer DJ. 2008. Circadian rhythm disturbances in depression. Hum Psychopharmacol. 23:571-585.
39. Germain A, Moul DE, Franzen PL, Miewald JM, Reynolds CF, Monk TH, Buysse DJ. 2006. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med. 2:403-406.
40. Germain A, Nofzinger EA, Meltzer CC, Wood A, Kupfer DJ, Moore RY, Buysse DJ. 2007. Diurnal variation in regional brain glucose metabolism in depression. Biol Psychiatry. 62:438-445.
41. Giles DE, Etzel BA, Biggs MM. 1990. Risk factors in unipolar depression: II. Relation between proband REM latency and cognitions of relatives. Psychiatry Res. 33:39-49.
42. Gillin JC, Buchsbaum MS, Valladares-Neto DC, Hong CC, Hazlett E, Langer SZ, Wu J. 1996. Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: a positron emission tomography study. Neuropsychopharmacology. 15:302-313.
43. Gordijn MC, Beersma DG, Bouhuys AL, Reinink E, Van denHoofdakker RH. 1994. A longitudinal study of diurnal mood variation in depression; characteristics and significance. J Affect Disord. 31:261-273.
44. Hamon M, Bourgoin S. 2006. Pharmacological profile of antidepressants: a likely basis for their efficacy and side effects? Eur Neuropsychopharmacol. 16:625-632.
45. Hattar S, Lucas RJ, Mrosovsky N, Thompson S, Douglas RH, Hankins MW, Lem J, Biel M, Hofmann F, Foster RG, Yau KW. 2003. Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature. 424:76-81.
46. Haynes PL, McQuaid JR, Ancoli-Israel S, Martin JL. 2006. Disrupting life events and the sleepwake cycle in Depression. Psychol Med. 36:1363-1373.
47. Heitzman J. 2009. Sleep disturbances: cause or result of depression. Psychiatr Pol. 43:499-511.
48. Hilger E, Praschak-Rieder N, Willeit M, Stastny J, Konstandinidis A, Neumeister A, Kasper S. 2002. Pharmacotherapy of seasonal depression. Nervenarzt. 73:22-29.
49. Howland RH. 2009. Somatic therapies for seasonal affective disorder. J Psychosoc Nurs Ment Health Serv. 47:17-20.
50. Hubain P, Le Bon O, Vandenhende F, Van Wijnendaele R, Linkowski P. 2006. Major depression in males: effects of age, severity and adaptation on sleep variables. Psychiatry Res. 145:169-177.
51. Joyce PR, Porter RJ, Mulder RT, Luty SE, McKenzie JM, Miller AL, Kennedy MA. 2005. Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms. Psychol Med. 35:511-517.
52. Karadottir R, Axelsson J. 2001. Melatonin secretion in SAD patients and healthy subjects matched with respect to age and sex. Int J Circumpolar Health. 60:548-551.
53. Kayumov L, Brown G, Jindal R, Buttoo K, Shapiro CM. 2001. A randomized, double-blind, placebo-controlled crossover study of the effect of exogenous melatonin on delayed sleep phase syndrome. Psychosom Med. 63:40-48.
54. Kennaway DJ, Moyer RW. 1998. Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms. Brain Res. 806:257-270.
55. Kennaway DJ, Moyer RW, Voultsios A, Varcoe TJ. 2001. Serotonin, excitatory amino acids and the photic control of melatonin rhythms and SCN c-FOS in the rat. Brain Res. 897:36-43.
56. Kennedy S, Emsley RA. 2006. Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol. 16:93-100.
57. Kennedy SH, Tighe S, McVey G, Brown GM. 1989. Melatonin and cortisol "switches" during mania, depression, and euthymia in a drug-free bipolar patient. J Nerv Ment Dis. 177:300-303.
58. Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R, Siever LJ. 2004. 24-h monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res. 38:503-511.
59. Kopp BT, Hayes D Jr, Ratkiewicz M, Baron N, Splaingard M. 2013. Light exposure and depression in hospitalized adult patients with cystic fibrosis. J Affect Disord. [Epub ahead of print].
60. Kumar VM. 2008. Sleep and sleep disorders. Indian J Chest Dis Allied Sci. 50:129-135.
61. Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH. 1981. Sleep and treatment prediction in endogenous depression. Am J Psychiatry. 138:429-434.
62. Lam RW, Levitt AJ, editors. 1999. Canadian consensus guidelines for the treatment of seasonal affective disorder. Vancouver: Clinical and Academic; p. 20-63.
63. Lam RW, Berkowitz AL, Berga SL, Clark CM, Kripke DF, Gillin JC. 1990. Melatonin suppression in bipolar and unipolar mood disorders. Psychiatry Res. 33:129-134.
64. Leibenluft E, Frank E. 2001. Circadian rhythms in affective disorders. In: Takahashi J, Turek F, Moore R, editors. Handbook of behavioral neurobiology: circadian clocks. New York (NY): Kluwer Academic/Plenum; p. 625-644.
65. Leproult R, Van Onderbergen A, L'Hermite-Baleriaux M, Van Cauter E, Copinschi G. 2005. Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men. Clin Endocrinol. 63:298-304.
66. Lewy AJ, Wehr T, Gold PW, Goodwin FK. 1979. Plasma melatonin in manic depressive illness. In: Usdin E, Kopin IJ, Barchas JD, editors. Catecholamines: basic and clinical frontiers (Vol. II). Oxford: Pergamon Press; p. 1173-1175.
67. Lewy AJ, Wehr TA, Goodwin FK, Newsome DA. 1981. Manic depressive patients may be supersensitive to light. Lancet. 1:383-384.
68. Lewy AJ, Bauer VK, Cutler NL, Sack RL, Ahmed S, Thomas KH, Blood ML, Jackson JM. 1998. Morning vs. evening light treatment of patients with winter depression. Arch Gen Psychiatry. 55:890-896.
69. Loning F, Cheng CL. 2003. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 3:350-361.
70. Lôo H, Hale A, D'Haenen H. 2002. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol. 17:239-247.
71. Loving RT, Kripke DF, Shuchter SR. 2002. Bright light augments antidepressant effects of medication and wake therapy. Depress Anxiety. 16:1-13.
72. Lustberg L, Reynolds CF. 2000. Depression and insomnia: questions of cause and effect. Sleep Med Rev. 4:253-262.
73. Macchi MM, Bruce JN. 2004. Human pineal physiology and functional significance of melatonin. Front Neuroendocrinol. 25:177-195.
74. Magnusson A, Partonen T. 2005. The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr. 10:625-634.
75. McCrae CS. 2009. Late-life comorbid insomnia: diagnosis and treatment. Am J Manag Care. 15: S14-S23.
76. Mendelson WB, Sack DA, James SP, Martin JV, Wagner R, Garnett D, Milton J, Wehr TA. 1987. Frequency analysis of the sleep EEG in depression. Psychiatry Res. 21:89-94.
77. Millan MJ, Gobert A, Lejeune F, Dekeyne A, Newman-Tancredi A, Pasteau V, Rivet JM, Cussac D. 2003. The novel melatonin agonist agomelatine (S20098) is an antagonist at 5-hydroxytryptamine 2C receptors, blockade of which enhances the activity of frontocortical dopaminergic and adrenergic pathways. J Pharmacol Exp Ther. 306:954-964.
78. Monk TH, Buysse DJ, Frank E, Kupfer DJ, Dettling J, Ritenour A. 1994a. Nocturnal and circadian body temperatures of depressed outpatients during symptomatic and recovered states. Psychiatry Res. 51:297-311.
79. Monk TH, Petrie SR, Hayes AJ, Kupfer DJ. 1994b. Regularity of daily life in relation to personality, age, gender, sleep quality and circadian rhythms. J Sleep Res. 3:196-205.
80. Montgomery SA. 2006. Major depressive disorders: clinical efficacy and tolerability of agomelatine, a new melatonergic agonist. Eur Neuropsychopharmacol. 16:633-638.
81. Moore RY. 1997. Circadian rhythms: basic neurobiology and clinical applications. Annu Rev Med. 48:253-266.
82. Moore RY. 2007. Suprachiasmatic nucleus in sleep-wake regulation. Sleep Med. 3:27-33.
83. Moscovici L, Kotler M. 2009. A multistage chronobiologic intervention for the treatment of depression: a pilot study. J Affect Disord. [Epub ahead of print].
84. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron. 34:13-25.
85. Nissen C, Nofzinger EA. 2007. Sleep and depression: a functional neuroimaging perspective. In: Pandi-Perumal SR, Ruoti RR, Kramer M, editors. Sleep and psychosomatic medicine. London: Informa Healthcare; p. 51-66.
86. Norman TR. 2013. Agomelatine, melatonin and depressive disorder. Expert Opin Investig Drugs. 22:407-410.
87. Nurnberger JI, Adkins S, Lahiri DK, Mayeda A, Hu K, Lewy A, Miller A, Bowman ES, Miller MJ, Rau L, Smiley C, Davis-Singh D. 2000. Melatonin suppession by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry. 57:572-579.
88. Nutt DJ. 2008. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry. 69:4-7.
89. Olié JP, Kasper S. 2007. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol. 10:661-673.
90. Paccierotti C, Iapichino S, Bossini L, Pieraccini F, Castrogiovanni P. 2001. Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol. 22:18-32.
91. Palazidou E, Papadopoulos A, Ratcliff H, Dawling S, Checkley SA. 1992. Noradrenaline uptake inhibition increases melatonin secretion, a measure of noradrenergic neurotransmission, in depressed patients. Psychol Med. 22:309-315.
92. Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poeggeler B, Hardeland R. 2006. Melatonin: nature's most versatile biological signal? FEBS J. 273:2813-2838.
93. Pandi-Perumal SR, Srinivasan V, Spence DW, Cardinali DP. 2007. Role of melatonin system in the control of sleep. CNS Drugs. 21:995-1018.
94. Peeters F, Nicolson NA, Berkhof J. 2003. Cortisol responses to daily events in major depressive disorder. Psychosom Med. 65:836-841.
95. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. 1997. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord. 42:209-212.
96. Pjrek E, Winkler D, Konstantinidis A, Willeit M, Praschak-Rieder N, Kasper S. 2007. Agomelatine in the treatment of seasonal affective disorder. Psychopharmacology (Berlin). 190:575-579.
97. Posener JA, DeBattista C, Williams GH, Kraemer HC, Kalehzan BM, Schatzberg AF. 2000. 24-hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch Gen Psychiatry. 57:755-760.
98. Pracka D. 1999. Phototherapy in the clinic. Postepy Hig Med Dosw. 53:517-523.
99. Rabe-Jablonska J, Szymanska A. 2001. Diurnal profile of melatonin secretion in the acute phase of major depression and in remission. Med Sci Monit. 7:946-952.
100. Reiter RJ, Korkmaz A. 2008. Clinical aspects of melatonin. Saudi Med J. 29:1537-1547.
101. Reyes DL, Guilleminault C. 2007. Sleep disorders as a major clinical manifestation of disturbed circadian rhythms in depression. Medicographia. 29:28-37.
102. Reynolds CF, Kupler D. 1988. Sleep in depression. In: Williams RZ, Karacan I, Moore CA, editors. Eep disorders, diagnosis and treatment. New York (NY): Wiley; p. 147-164.
103. Riedel WJ, Klaassen T, Griez E, Honig A, Menheere PPCA, Van Praag HM. 2002. Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor- specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology. 26:358-367.
104. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, Mueller PS, Newsome DA, Wehr TA. 1984. Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 41:72-80.
105. Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, Rahman Z, Ring RH, Schechter LE. 2007. Differentiating antidepressants of the future: efficacy and safety. Pharmacol Ther. 113:134-153.
106. Rossenwasser AM, Wirz-Justice A. 1997. Circadian rhythms and depression: clinical and experimental models. In: Redfern P, Lemmer B, editors. Handbook of experimental pharmacology: physiology and pharmacology of biological rhythms. Vol. 125, Springer: Berlin; p. 457-461, 464-479.
107. Sachs G. 2008. Psychosocial interventions as adjunctive therapy for bipolar disorder. J Psychiatr Pract. 14:39-44.
108. Sack RL, Lewy AJ, White DM, Singer CM, Fireman MJ, Vandiver R. 1990. Morning vs. evening light treatment for winter depression. Evidence that the therapeutic effects of light are mediated by circadian phase shifts. Arch Gen Psychiatry. 47:343-351.
109. Saeed SA, Bruce TJ. 1998. Seasonal affective disorders. Am Fam Physician. 57:1340-1346.
110. Salva MA, Vanier B, Laredo J, Hartley S, Chapotot F, Moulin C, Lofaso F, Guilleminault C. 2007. Major depressive disorder, sleep EEG and agomelatine: an open-label study. Int J Neuropsychopharmacol. 10:691-696.
111. Saper CB, Scammell TE, Lu J. 2005. Hypothalamic regulation of sleep and circadian rhythms. Nature. 437:1257-1263.
112. Serretti A, Cusin C, Benedetti F, Mandelli L, Pirovano A, Zanardi R, Colombo C, Smeraldi E. 2005. Insomnia improvement during antidepressant treatment and clock gene polymorphism. Am J Med Genet B Neuropsychiatr Genet. 137:36-39.
113. Shaffery J, Hoffmann R, Armitage R. 2003. The neurobiology of depression: perspectives from animal and human sleep studies. Neuroscientist. 9:82-98.
114. Shochat T, Luboshitzky R, Lavie P. 1997. Nocturnal melatonin onset is phase locked to the primary sleep gate. Am J Physiol. 273:364-370.
115. Sitaram N, Gillin JC, Bunney WE. 1978. The switch process in manic-depressive illness. Circadian variation in time of switch and sleep and manic ratings before and after switch. Acta Psychiatr Scand. 58:267-278.
116. Souetre E, Salvati E, Belugou JL, Pringuey D, Candito M, Krebs B, Ardisson JL, Darcourt G. 1989. Circadian rhythms in depression and recovery: evidence for blunted amplitude as the main chronobiological abnormality. Psychiatry Res. 28:263-278.
117. Stephan FK, Zucker I. 1972. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Nat Acad Sci USA. 69:1583-1586.
118. Stetler C, Dickerson SS, Miller GE. 2004. Uncoupling of social zeitgebers and diurnal cortisol secretion in clinical depression. Psychoneuroendocrinology. 29:1250-1259.
119. Sumaya IC, Rienzi BM, Deegan JF, Moss DE. 2001. Bright light treatment decreases depression in institutionalized older adults: a placebo-controlled crossover study. J Gerontol A Biol Sci Med Sci. 56:356-360.
120. Szuba MP, Yager A, Guze BH, Allen EM, Baxter Jr. 1992. Disruption of social circadian rhythms in major depression: a preliminary report. Psychiatry Res. 42:221-230.
121. Tardito D, Molteni R, Popoli M, Racagni G. 2012. Synergistic mechanisms involved in the antidepressant effects of agomelatine. Eur Neuropsychopharmacol. 22:482-486.
122. Taylor DJ, Lichstein KL, Weinstock J, Sanford S, Temple Jr. 2007. A pilot study of cognitivebehavioral therapy of insomnia in people with mild depression. Behav Ther. 38:49-57.
123. Terman M, Terman JS. 1999. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry. 60:799-808.
124. Terman M, Terman JS, Ross DC. 1998. A controlled trial of timed bright light and negative air ionization for treatment of winter depression. Arch Gen Psychiatry. 55:875-882.
125. Terman JS, Terman M, Lo ES, Cooper TB. 2001. Circadian time of morning light administration and therapeutic response in winter depression. Arch Gen Psychiatry. 58:69-75.
126. Tolle R, Goetze U. 1987. On the daily rhythm of depression symptomatology. Psychopathology. 20:237-249.
127. Tsuno N, Besset A, Ritchie K. 2005. Sleep and depression. J Clin Psychiatry. 66:1254-1269.
128. Tuunainen A, Kripke DF, Endo T. 2004. Light therapy for nonseasonal depression. Cochrane Database Syst Rev, (2), CD004050.
129. Tzischinsky O, Shlitner A, Lavie P. 1993. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfatoxymelatonin. J Biol Rhythms. 8:199-209.
130. Urretavizcaya M, Soria V, Cambras, T. 2006. Ritmos biológicos y enfermedad mental [Biological rhythms and mental illness]. In: Madrid J, Rol de Lama A, Editors. Cronobiología Básica y Clínica [Basic and clinical chronobiology]. Madrid: Editecred; p. 777-789.
131. Wehr T, Goodwin FK. 1979. Tricyclics modulate frequency of mood cycles. Chronobiologia. 6:377-385.
132. Wehr TA, Wirz-Justice A. 1982. Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria. 15:31-39.
133. West AE, Pavuluri MN. 2009. Psychosocial treatments for childhood and adolescent bipolar disorder. Child Adolesc Psychiatr Clin N Am. 18:471-482.
134. Wetterberg L, Aperia B, Gorelick DA, Gwirtzman HE, McGuire MT, Serafetinides EA, Yuwiler A. 1992. Age, alcoholism and depression are associated with low levels of urinary melatonin. J Psychiatry Neurosci. 17:215-224.
135. Winkler D, Pjrek E, Iwaki R, Kasper S. 2006. Treatment of seasonal affective disorder. Expert Rev Neurother. 6:1039-1048.
136. Wirz-Justice A. 2006. Biological rhythm disturbances in mood disorders. Int Clin Psychopharmacol. 21:11-15.
137. Wirz-Justice A, Van den Hoofdakker RH. 1999. Sleep deprivation in depression: what do we know, where do we go? Biol Psychiatry. 46:445-453.
138. Wirz-Justice A, Benedetti F, Berger M, Lam RW, Martiny K, Terman M, Wu JC. 2005. Chronotherapeutics (light and wake therapy) in affective disorders. Psychol Med. 35:939-944.
139. Wu JC, Bunney WE. 1990. The biological basis of an antidepressant response to sleep deprivationand relapse: review and hypothesis. Am J Psychiatry. 147:14-21.
140. Zisapel N. 2001. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs. 15:311-328.
141. Zupancic M, Guilleminault C. 2006. Agomelatine: a preliminary review of a new antidepressant. CNS Drugs. 20:981-992.